Clinical Trials
Closed
Phase
SWOG Clinical Trial Number
SWOG-7418
Combination Chemotherapy of Multiple Myeloma in Perviously Untreated Patients
Activated
10-01-1974
Closed
03-01-1977
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7406
MOPP #5 in Advanced Hodgkin's Disease
Activated
08-23-1974
Closed
06-07-1978
Closed
Phase
SWOG Clinical Trial Number
SWOG-7410
Chronic Lymphocytic Leukemia - CAP in Remission Induction, Prednisone and Cyclophosphamide for Maintenance
Activated
07-10-1974
Closed
10-16-1979
Closed
Phase
SWOG Clinical Trial Number
SWOG-7404
RT + CCNU and Procarbazine vs. RT + CCNU Followed by the Sequential Use of Procarbazine after Relapse in Patients with Malignant Gliomas
Activated
06-25-1974
Closed
03-07-1977
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7315/16
Remission Induction for Adult Acute Leukemia with Ten-day OAP Remission Maintenance with OAP vs OAP plus BCG
Activated
07-06-1973
Closed
01-01-1977
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-7204/7205
Non-Hodgkin's Lymphoma CHOP vs. HOP Combination Chemotherapy for Remission Induction and COP vs. OAP Combination Chemotherapy for Maintenance
Research Committee(s)
Lymphoma
Activated
04-17-1972
Closed
09-10-1974
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-781
Radiotherapy - Chemotherapy (MOPP) for Stages I and II, A and B Hodgkin's
Activated
02-14-1972
Closed
08-08-1978
Closed
Phase
SWOG Clinical Trial Number
SWOG-780
Combination Cyclophosphamide, Vincristine, Prednisone and Bleomycin for Non-Hodgkin's Lymphoma
Activated
11-04-1971
Closed
02-08-1973
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-774/775
Hodgkin's Disease: Remission Induction with Mustargen, Oncovin, Prednisone and Procarbazine + Bleomycin (MOPP#4)
Activated
07-20-1971
Closed
08-23-1974
Closed
Phase
SWOG Clinical Trial Number
SWOG-160
Combined Radiotherapy and Chemotherapy for Stage II B, Stage III A and Stage III B Hodgkin's Disease
Activated
03-18-1971
Closed
02-21-1975
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-440
Bleomycin for Solid Tumors and Lymphomas
Activated
12-11-1970
Closed
07-01-1971
Closed
Phase
Accrual
91%
SWOG Clinical Trial Number
SWOG-438
Closed
Phase
Accrual
53%
SWOG Clinical Trial Number
SWOG-437
Closed
Phase
SWOG Clinical Trial Number
SWOG-772/773
Hodgkin's Disease: Remission Consolidation with Actinomycin D, Vinblastine, and Methotrexate (MOPP#3)
Activated
10-08-1969
Closed
11-09-1971
Closed
Phase
Accrual
1%
SWOG Clinical Trial Number
SWOG-229
Study of Dibromomannitol in Chronic Granulocytic Leukemia
Activated
08-06-1969
Closed
Phase
Accrual
58%
SWOG Clinical Trial Number
SWOG-434
Imidazole Carboxamide Dimethyl Triazene (NSC-45388) in Patients with Solid Tumors (Excluding Melanomas, Lymphomas, and Breast Cancer)
Activated
05-20-1969
Closed
06-24-1970
Closed
Phase
Accrual
9%
SWOG Clinical Trial Number
SWOG-431
Evaluation of Bis-Chlorethyl-nitrosourea (BCNU) in Multiple Myeloma
Research Committee(s)
Myeloma
Activated
04-16-1969
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
SWOG-227
Protocol for Phase II Trial of Actinomycin D & Vincristine in Lung Cancer
Activated
08-06-1968
Closed
08-21-1969
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
SWOG-717
Closed
Phase
SWOG Clinical Trial Number
SWOG-756/759
Combination Chemotherapy in Advanced Hodgkin's Disease: Induction and Maintenance of Remission
Activated
09-29-1967
Closed
09-01-1973